NinePointTwo Capital’s Abiomed Inc ABMD Stock Holding History

NinePointTwo Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-842	Closed	-$206K	–	288
2022 Q3	$206K	Hold	842	–	–	0.08%	154
2022 Q2	$208K	Buy	842 +3	+0.4%	+$810	0.07%	168
2022 Q1	$277K	Hold	839	–	–	0.07%	131
2021 Q4	$301K	Buy	+839	New	+$283K	0.1%	61

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NinePointTwo Capital's ABMD Position: Q4 2022 in Review

NinePointTwo Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 842 shares — an estimated $206K sold.

NinePointTwo Capital first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $301K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

NinePointTwo Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
NinePointTwo Capital sold 842 Abiomed Inc shares in Q4 2022, an estimated $206K.
NinePointTwo Capital first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
NinePointTwo Capital's Abiomed Inc position peaked at $301K in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.